Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
BJU International
|
February 22, 2017
Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients
Martin Spahn, Alessandro Morlacco, Silvan Boxler, et al.
Medical Physics
|
September 24, 2017
Assessment of a photon-counting detector for a dual-energy C-arm angiographic system
Moiz Ahmad, Rebecca Fahrig, Leland Pung, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2014
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
Kirill Litovkin, Steven Joniau, Evelyne Lerut, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2024
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
Csilla Olah, Fabian Mairinger, Michael Wessolly, et al.
BMC Cancer
|
December 18, 2019
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
Eugenio Zoni, Martina Minoli, Cédric Bovet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 30, 2010
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers
Martin Fassnacht, Sarah Johanssen, Wiebke Fenske, et al.
The Lancet. Oncology
|
April 4, 2014
Radiotherapy for renal-cell carcinoma
Gert De Meerleer, Vincent Khoo, Bernard Escudier, et al.
Biomed Research International
|
December 13, 2019
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
Markus Krebs, Christoph Behrmann, Charis Kalogirou, et al.
Journal of Clinical Medicine
|
March 6, 2020
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs, Antonio Giovanni Solimando, Charis Kalogirou, et al.
The Journal of Urology
|
May 15, 2012
Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease
Martin Spahn, Alberto Briganti, Umberto Capitanio, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
BJU International
|
February 22, 2017
Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients
Martin Spahn, Alessandro Morlacco, Silvan Boxler, et al.
Medical Physics
|
September 24, 2017
Assessment of a photon-counting detector for a dual-energy C-arm angiographic system
Moiz Ahmad, Rebecca Fahrig, Leland Pung, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2014
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
Kirill Litovkin, Steven Joniau, Evelyne Lerut, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2024
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
Csilla Olah, Fabian Mairinger, Michael Wessolly, et al.
BMC Cancer
|
December 18, 2019
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
Eugenio Zoni, Martina Minoli, Cédric Bovet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 30, 2010
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers
Martin Fassnacht, Sarah Johanssen, Wiebke Fenske, et al.
The Lancet. Oncology
|
April 4, 2014
Radiotherapy for renal-cell carcinoma
Gert De Meerleer, Vincent Khoo, Bernard Escudier, et al.
Biomed Research International
|
December 13, 2019
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
Markus Krebs, Christoph Behrmann, Charis Kalogirou, et al.
Journal of Clinical Medicine
|
March 6, 2020
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs, Antonio Giovanni Solimando, Charis Kalogirou, et al.
The Journal of Urology
|
May 15, 2012
Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease
Martin Spahn, Alberto Briganti, Umberto Capitanio, et al.
Page
of 11